XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact
The Pharma Data
JANUARY 27, 2021
Construction of commercial drug manufacturing facility in Germany. Development of oral biosensor and contract development & manufacturing. Psychedelic transdermal and sublingual drug formulation development. Four clinical studies in neurological indications in 2021.
Let's personalize your content